Clinical trial
Shift to Everolimus (RAD) Kidney Sparing Study
NCT00420537 · University of Bologna, Other · Terminated
Key facts
| NCT number | NCT00420537 |
|---|---|
| Title | Shift to Everolimus (RAD) Kidney Sparing Study |
| Official title | Safety and Efficacy of Low-dose Cyclosporine in Association With Everolimus to Minimize Renal Dysfunction in Heart Transplant Recipients |
| Lead sponsor | University of Bologna, Other |
| Status | Terminated |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Kidney Dysfunction, Heart Transplantation |
| Intervention type | Drug |
| Interventions | cyclosporine, Mycophenolate mofetil, Everolimus |
| Enrollment | 34 |
| Start date | Sep 1, 2006 |
| Primary completion | Jan 1, 2009 |
| Completion | Mar 1, 2009 |
| First posted | Jan 11, 2007 |
| Last update posted | Jan 12, 2010 |
| Countries | Italy |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: